May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Neuroprotection of Ischemic Injury in Pig Retina, Part III-- Functional Assessment
Author Affiliations & Notes
  • E. B. Lavik
    Biomedical Engineering, Yale University, New Haven, Connecticut
  • M. Voss Kyhn
    Eye Department, Rigshospitalet, Copenhagen, Denmark
  • K. Warfvinge
    Department of Ophthalmology, Lund University, Lund, Sweden
  • J. Folke Kiigaard
    Eye Department, Glostrup Hospital, Copenhagen, Denmark
  • E. Scherfig
    Eye Department Rigshospitalet and Eye Pathology Institute, Copenhagen University, Copenhagen, Denmark
  • M. la Cour
    Eye Department, Rigshospitalet, Copenhagen, Denmark
  • H. Klassen
    Department of Ophthalmology, University of California, Irvine, Irvine, California
  • M. Young
    Department of Ophthalmology, Schepens Eye Research Institute, Harvard University, Boston, Massachusetts
  • Footnotes
    Commercial Relationships E.B. Lavik, None; M. Voss Kyhn, None; K. Warfvinge, None; J. Folke Kiigaard, None; E. Scherfig, None; M. la Cour, None; H. Klassen, None; M. Young, None.
  • Footnotes
    Support Gift of Richard and Gail Siegal
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 568. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. B. Lavik, M. Voss Kyhn, K. Warfvinge, J. Folke Kiigaard, E. Scherfig, M. la Cour, H. Klassen, M. Young; Neuroprotection of Ischemic Injury in Pig Retina, Part III-- Functional Assessment. Invest. Ophthalmol. Vis. Sci. 2007;48(13):568.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: GDNF is neuroprotective for retinal ganglion cells. We sought to test whether sustained delivery of GDNF over 6 weeks could lead to improvements in function in a porcine model of acute retinal ischemia induced by transient low ocular perfusion pressure (OPP).Material and

Methods:: A total of 9 animals were included in the study. A model of OPP was induced in pigs by monitoring and maintaining an IOP 5 mm Hg below the mean arterial pressure for 2 hours in the left eye. 3 days after OPP induction, a small vitrectomy was performed over the optic nerve head and 0.1 ml of either GDNF microspheres or blank microspheres in PBS at a concentration of 10 mg/ml were injected intravitreally in 7 pigs. Animals were evaluated with a slow-stimulation sequence mfERG-protocol at baseline before the low OPP procedure, at day 3 before injection of the microspheres and at days 14, 28 and 42 after injection of the microspheres. Another 2 animals received the injection without previous vitrectomy on the same day following the induction of the low OPP. mfERG was recorded at baseline before induction of low OPP and at day 21 after microsphere injection for these animals.

Results:: The induced components in the late mfERG responses were evaluated. A negative amplitude deflection (iN1) at approximately 50 ms was the most consistent finding. 3 days before the injection of microspheres, the iN1 amplitudes were reduced to 2 - 22% of the amplitude in the untreated eye. At the last day of examinations the iN1 amplitude were reduced to 16-47 % of the amplitude in the untreated eye in GDNF treatment compared to a reduction to 1-4% in blank controls (p=0.012).

Conclusions:: The sustained delivery of GDNF in this model leads to improved function as compared to blank polymer controls. Taken with the results in parts I and II, we have developed a method which leads to degeneration of the RGCs. GDNF preserves the function of RGCs in this model suggesting a role for neuroprotection in the pig eye. This improved function correlates with the histology, and suggests that sustained delivery of GDNF may lead to functional neuroprotection in diseases affecting the optic nerve.

Keywords: ischemia • ganglion cells • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×